Development of retinoblastoma in the absence of telomerase activity

Journal of the National Cancer Institute

Volumn 88, Issue 16, 1996, Pages 1152-1157

  Gupta, Jyothi ^a   Han, Li Ping ^b   Wang, Ping ^a   Gallie, Brenda L ^b   Bacchetti, Silvia ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOGENESIS; ENZYME ACTIVITY; ENZYME ASSAY; GENE MUTATION; RETINOBLASTOMA; TELOMERE;

EID: 0029790387     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.16.1152     Document Type: Article

References (41)

1. Bacchetti S, Counter CM. Telomeres and telomerase in human cancer. Int J Oncol 1995;7:423-32.
2. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
3. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59: 521-9.
4. Greider CW. Telomerase biochemistry and regulation. In: Blackburn EH, Greider CW, editors. Telomeres. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 1995: 35-68.
5. Biessmann H, Mason JM. Genetics and molecular biology of telomeres. Adv Genet 1992;30:185-249.
6. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
7. Olovnikov AM. Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR 1971;201:394-7.
8. Watson JD. Origin of concatemeric T7 DNA. Nature New Biol 1972;239:197-201.
9. Olovnikov AM. A theory of marginotomy: the incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-90.
10. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-82.
11. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-60.
12. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992;89:10114-8.
13. Harley CB. Telomeres and aging. In: Blackburn EH, Greider CW, editors. Telomeres. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 1995:247-63.
14. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
15. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68:3410-4.
16. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 1995;15:425-32.
17. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL. et al. Specific association of human telomerase activity with immortal cells and cancer [see comment citation in Medline]. Science 1994;266:2011-5.
18. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994;59:307-15.
19. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56:645-50.
20. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma [see comment citation in Medline]. Proc Natl Acad Sci U S A 1995;91:2900-4.
21. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
22. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-20.
23. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994;9:3043-8.
24. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes [see comment citation in Medline]. Nat Med 1995;1:249-55.
25. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers [see comment citation in Medline]. J Natl Cancer Inst 1995;87:895-902.
26. Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 1995;75:1094-9.
27. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995; 92:9082-6.
28. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
29. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-22.
30. Gallie BL, Hel HJ, Dunn JM. Retinoblastoma: for the next generation. In: Cowell J, editor. Cancer genetics. London: Bios, 1995:1-29.
31. Dunn JM, Phillips RA, Becker AJ, Gallie BL. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988;241:1797-800.
32. Squire J, Gallie BL, Phillips RA. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 1985;70:291-301.
33. Hamel PA, Phillips RA, Muncaster M, Gallie BL. Speculations on the roles of RBI in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J 1993;7:846-54.
34. Filmus J, Trent JM, Pollak NM, Buick RN. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol Cell Biol 1987;7:251-7.
35. Muncaster MM, Cohen BL, Phillips RA, Gallie BL. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res 1992;52:654-61.
36. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-72.
37. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334:124-9.
38. Chadeneau C, Siegel P, Harley CB, Muller WJ, Bacchetti S. Telomerase activity in normal and malignant murine tissues. Oncogene 1995;11:893-8.
39. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW. Telomerase activity in human brain tumors. Lancet 1995;346:1267-8.
40. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBOJ 1995;14:4240-8.
41. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155:3711-5.